Selling Blue Bottle Below Cost
Nestle agreed to sell Blue Bottle Coffee to Centurium Capital, a China-based investment firm, in a deal expected to close in the first half of 2026, per BeverageDaily. The price was not disclosed but was reported below the $425 million Nestle paid for the brand less than a decade ago. That gap is not a rounding error. It is a direct statement that brand-led café expansion did not return what big food expected when it moved into the service channel.
The deal structure tells you what Nestle is keeping. Nespresso-compatible pod rights stay with Nestle. The cafés and the consumer packaged goods operations transfer to Centurium. So Nestle retains the part of Blue Bottle that feeds its existing high-margin coffee system and exits the part that required a different operating model, physical retail, staffing, and a service culture, that the company was not built to run at scale.
Nestle's stated direction, per the same report, is to concentrate on what leadership calls "scalable, high-margin coffee formats: pods, instant, and ready-to-drink." That framing is a useful signal for your own portfolio planning if you compete in or alongside the coffee aisle. Nestle is not retreating from coffee. It is narrowing to the formats where it has structural cost and distribution advantages.
The Alt-Cocoa Bet in Confectionery
On the input cost side of confectionery, Nestle is using ChoViva, a sunflower-based cocoa ingredient developed by Planet A Foods, per ConfectioneryNews coverage of the alt-chocolate space. Barry Callebaut is also using ChoViva, and Mondelez, Lindt & Sprüngli, and Cargill are all investing in their own alternative cocoa technologies.
This is not a small-batch experiment. The capital allocation across the industry looks structural rather than pilot-scale. Cocoa prices have been volatile and have risen sharply in recent years, and manufacturers are actively building supply chain optionality. For Nestle specifically, the ChoViva move is a hedge: if the ingredient can be used at meaningful scale without a consumer rejection, it reduces exposure to cocoa price spikes in at least part of the portfolio.
Consumer adoption of alt-cocoa remains largely unproven at this point, and that matters. You can model a cost benefit on the supply side, but if shoppers notice a taste or texture difference and trade down or switch brands, the saving evaporates. Nestle and the others are betting that formulation quality has reached a point where the trade-off is acceptable. Whether that proves true will show up in category scanner data over the next several quarters.
What to Watch in the Next Reported Period
The source material available for this piece covers strategic and partnership signals rather than the most recent quarterly financials. When Nestle's next earnings update is published, the numbers to track are: organic sales growth split between real internal growth (the volume and mix component) and pricing; the margin trajectory in the confectionery and coffee segments separately; and any commentary on portfolio shaping, specifically whether further asset sales or acquisitions are flagged.
The Blue Bottle exit and the ChoViva ingredient adoption point in the same direction. Nestle is prioritizing margin quality over topline breadth. If the next reported numbers show that coffee pod and instant formats are growing faster than the café-adjacent and mainstream chocolate lines, that thesis gets confirmation. If volume is still soft even after price increases moderate, the portfolio concentration story becomes more urgent, not less.
For commercial teams working in coffee or confectionery, the practical implication is straightforward. Nestle is likely to invest more aggressively behind the formats and products it is keeping, so expect sharper promotional activity and stronger in-store presence in pods and ready-to-drink coffee in the periods ahead.